0I7E

DaVita Inc.

Stock London Stock Exchange – Stock Market Prices, News & Analysis

Fournisseur de services de santé spécialisé dans le traitement de l'insuffisance rénale chronique par dialyse, opérant principalement aux États-Unis.

£ 1.50
1.67 %

DaVita Inc.

£ 1.50
1.67 %
0I7E

Fournisseur de services de santé spécialisé dans le traitement de l'insuffisance rénale chronique par dialyse, opérant principalement aux États-Unis.

Price history of DaVita Inc.
Price history of DaVita Inc.

Performance & Momentum

6 Months 11.39 %
1 Year 7.36 %
3 Years 85.22 %
5 Years 39.03 %

Strategic Analysis

DaVita Inc. • 2026

DaVita Inc. positions itself as a major player in specialized medical services for dialysis treatment of chronic kidney failure in the United States. Its business model is built on operational expertise and a strong footprint in a healthcare segment with structurally growing demand, driven by aging demographics and the prevalence of kidney disease.

Strengths
  • Clear specialization in a niche medical field with high barriers to entry
  • Recurring business model based on essential treatments that are often covered by health insurance
  • Sustained long-term growth, illustrating an ability to capture durable demand
Weaknesses
  • Heavy dependence on the U.S. healthcare system and its regulations
  • Exposure to risks related to changes in reimbursement and operating costs
Momentum

Current momentum is positive, supported by a favorable performance trend over several years. This dynamic reflects confidence in the resilience of the business model despite a complex regulatory environment. However, the absence of recent news suggests monitoring the impact of policy changes in the healthcare sector.

Similar stocks to DaVita Inc.

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone